Trials / Unknown
UnknownNCT01152060
Treatment for HBV-MN Patients in Chinese: An Open Parallel Controlled Trial
an Open Parallel Clinical Trial in HBV-GN Patients
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 10 (estimated)
- Sponsor
- Nanchang University · Academic / Other
- Sex
- All
- Age
- 18 Years – 60 Years
- Healthy volunteers
- Not accepted
Summary
Lamivudine treatment for HBV-DNA negative HBV-GN patients.
Detailed description
lamivudine and predinisone treatment for HBV-DNA negative HBV-GN patients.
Conditions
Timeline
- Start date
- 2010-01-01
- Primary completion
- 2010-11-01
- Completion
- 2010-11-01
- First posted
- 2010-06-29
- Last updated
- 2010-06-29
Source: ClinicalTrials.gov record NCT01152060. Inclusion in this directory is not an endorsement.